Theranostics in Cancer Management

Integrating Diagnostics and Therapeutic Strategies
Erscheinungsjahr 2025
ISBN: 978-0-443-34199-1
Verlag: Elsevier Science

Buch, Englisch, 440 Seiten, Format (B × H): 191 mm x 235 mm

Theranostics in Cancer Management: Integrating Diagnostics and Therapeutic Strategies introduces a transformative paradigm in clinical oncology, heralding a new era of precision and personalized cancer care. This comprehensive guide empowers clinicians by seamlessly integrating advanced diagnostics with targeted therapeutic approaches. The book provides an extensive exploration of theranostics across diverse clinical scenarios, ensuring that healthcare professionals are equipped with the knowledge to navigate the complexities of cancer management effectively. Beyond the introductory insights, the book delves into several types of cancer and the utilization of Artificial Intelligence in cancer detection tools.

Comprising 15 chapters, it offers an invaluable resource for health professionals, scientists, researchers, practitioners, and students who seek to expand their understanding in this evolving field. The emphasis on practical applications and emerging technologies makes it a timely addition to the field of oncology.

Autoren/Hrsg.

Bhatt, Shvetank

Anitha, Kuttiappan

Chenchula, Santenna

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie

Inhaltsverzeichnis

1. Introduction to Theranostics in oncology
2. Theranostics in Breast Cancer
3. Theranostics in Gastric and Colorectal cancer
4. Theranostics in Cervical Cancer
5. Theranostics in Lung Cancer
6. Theranostics in Hepatocellular Carcinoma
7. Theranostics in Brain cancer
8. Theranostics in Pancreatic Cancer
9. Theranostics in Prostate Cancer
10. Theranostics in Ovarian Cancer
11. Theranostics in Bone Cancer
12. Theranostics in Skin cancer
13. Challenges and Limitations of Theranostics in Precision Oncology
14. Recent evidence of Theranostics and its Perspectives on Clinical Advances and Emerging Approaches
15. Theranostics and Artificial Intelligence as Tools to Detect various cancer

Über Autor(innen)

Bhatt, Shvetank
Dr. Shvetank Bhatt is an accomplished Associate Professor in the School of Health Sciences and Technology at Dr. Vishwanath Karad MIT World Peace University, located in Pune, Maharashtra, India. He holds an M. Pharm degree in Pharmacology from Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka, and a Ph.D. in Neuropharmacology from Birla Institute of Technology & Science (BITS) Pilani, Pilani Campus, Rajasthan. With many years of industrial and academic research experience, Dr. Bhatt specializes in CNS disorders, pain, inflammation, and immuno-oncology. He has received numerous accolades, including the Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award for Best Paper in Pharmacology-IJPER in 2012 and 2014. Dr. Bhatt has published dozens of papers in various national and international journals. Dr. Bhatt is a life member of the Association of Pharmaceutical Teachers of India (APTI) and the Indian Pharmacological Society (IPS).

Chenchula, Santenna
Dr. Santenna Chenchula has been an academic faculty member and researcher in the Department of Pharmacology at the All India Institute of Medical Sciences (AIIMS) Bhopal. His research interests span across clinical pharmacology, with a focus on molecular medicine, precision medicine, pharmacogenomics, oncology, rational drug use, antimicrobial resistance, vaccines, drug discovery, clinical trials, and pharmacovigilance. He serves as a reviewer for several national and international journals in the field of biomedical research. To date, he has published dozens of articles in international and national journals and has authored several books as the corresponding first author. He is an active member of the Pharmacogenomics Research Network (PGRN), The American Society for Clinical Pharmacology and Therapeutics (ASCPT), and the Global Center for Evidence Synthesis (GCES). Currently, he is pursuing a PhD in clinical pharmacology, specializing in Precision Medicine and Pharmacogenomics.